Latest news

Thumbnail image for Celebrating excellence in international clinical research

Celebrating excellence in international clinical research

The final entry deadline for the International Clinical Researcher of the Year 2017 competition has now passed, and the finalists have been invited to compete at the rigorous Final Day. Who will be awarded the coveted Pharma in front of an audience of their industry peers?

24th February 2017

Thumbnail image for Mundipharma to launch Mabthera biosimilar in EU markets

Mundipharma to launch Mabthera biosimilar in EU markets

Mundipharma is gearing up to launch biosimilar Truxima in seven European markets for the treatment of certain cancers and inflammatory conditions, after Celltrion bagged a regulatory approval for the drug.

23rd February 2017

Thumbnail image for Bowel scope screening cuts cancer and death rate

Bowel scope screening cuts cancer and death rate

A one-off screening test called Bowel Scope cuts the risk of developing bowel cancer by more than one third and could save thousands of lives, according to a new study published in The Lancet.

23rd February 2017

Thumbnail image for Priority review for Pfizer’s ALL drug

Priority review for Pfizer’s ALL drug

US regulators have agreed to undertake a speedy review of Pfizer's experimental drug inotuzumab ozogamicin as a treatment for adult patients with relapsed or refractory B-cell precursor acute lymphoblastic leukemia (ALL).

22nd February 2017

Thumbnail image for MSD, Wayra unveil Velocity Health winners

MSD, Wayra unveil Velocity Health winners

Merck Sharp & Dohme (MSD) and Wayra UK have unveiled the 2017 winners of Velocity Health, a ground-breaking preventative digital healthcare accelerator programme designed to address key care challenges.

22nd February 2017

Thumbnail image for Final NICE yes for Amicus’ Fabry disease drug

Final NICE yes for Amicus’ Fabry disease drug

Cost regulators for NHS therapies in England and Wales have now published final guidelines endorsing the use of Amicus Therapeutics' Galafold for treating the rare genetic disorder Fabry disease.

22nd February 2017

Thumbnail image for BMA report highlights NHS bed crisis

BMA report highlights NHS bed crisis

The number of overnight hospital beds available to patients in England has decreased by a fifth in a decade, according to research by the British Medical Association.

21st February 2017

Thumbnail image for NHS books £886m year-to-date deficit

NHS books £886m year-to-date deficit

The NHS provider sector has generated a year-to-date deficit of £886 million, with the sector forecasting a year-end deficit of £873 million, show figures published by NHS Improvement.

21st February 2017

Thumbnail image for NICE draft guidelines reject Ipsen’s Cabometyx

NICE draft guidelines reject Ipsen’s Cabometyx

The National Institute for Health and Care Excellence has issued its first draft guidelines on Ipsen's Cabometyx, recommending against the drug's routine use on the National Health Service as a treatment for pre-treated advanced renal cell carcinoma.

21st February 2017

Previous  --   1 2 3 4 5 6 7 8 9 10   --  Next

Download our apps

Go to the App Store or Google Play and search for 'PharmaTimes' to download our free app.

Go to the App Store or Google Play and search for 'PharmaTimes' to download our free app.

Download